top of page

Thu, Apr 18

|

Online via Zoom

InnovatorMD Startup Showcase

Discover groundbreaking startups revolutionizing healthcare. Hear from visionary founders like Dr. Jose Balanos, CEO of Nimbus-T Global, Dr. Prem Sahasranam, CEO of My Diabetes Tutor and BK. Kishore, MD, Ph.D., MBA, Co-founder, President, CEO & CSO of ePurines, Inc.

InnovatorMD Startup Showcase
InnovatorMD Startup Showcase

Time & Location

Apr 18, 2024, 5:00 PM – 6:30 PM

Online via Zoom

About the Event

Get ready for an evening of innovation and inspiration at the InnovatorMD Startup Showcase on April 18th, taking place online via Zoom from 5:00 to 6:30 PM PST!

Calling all investors, entrepreneurs, physicians, and healthcare innovators - this event is for you! Join us as we hear from visionary leaders who are revolutionizing the healthcare landscape with their groundbreaking startups.

  • Jose Balanos, MD, CEO and Founder of Nimbus-T Global Inc. The digital world is being attacked and the main entry point is the login access. Over 20 Billion passwords are on the dark web and the average ransomware is $10 million. Once the enterprise system is accessed with administrator privileges (SSO), access to the entire system will create major problems. Our patented Nimbus-Key ID system is providing a higher level of security with KYC/AI/Biometric user registration on our Nimbus-Key ID mobile app.
  • Prem Sahasranam, MD, Board Certified Endocrinologist and Chief Executive Officer of My Diabetes Tutor. Diabetes is complex. Patient education is critical. It’s why so many doctors are turning to the breakthrough My Diabetes Tutor telehealth solution. In this session, hear Dr. Prem Sahasranam, Board Certified Endocrinologist and Founder, CEO, and Chief Medical Officer, My Diabetes Tutor, discuss:
  1. The challenges of unmanaged diabetes
  2. Why education is a game-changer for patients and providers alike
  3. The impressive outcomes My Diabetes Tutor is creating for thousands of patients
  • BK. Kishore, MD, Ph.D., MBA, Co-founder, President, CEO & CSO of ePurines, Inc. Diet-induced obesity is a global problem leading to metabolic syndrome, diabetes mellitus, and other non-communicable diseases (NCDs). Two-thirds of the affected people are in the developing world, which is not targeted by current anti-obesity drugs, thus leaving a huge unmet need. Based on patented technology, ePurines aims to develop orally effective small molecule P2Y2 receptor antagonists as potential drugs to prevent and/or treat diet-induced obesity, as well NCDs at an affordable price.

Don't miss this opportunity to be inspired by these visionary founders and their impactful work. Mark your calendars and join us for an evening of insights, networking, and celebration of healthcare innovation!

#InnovatorMD #StartupShowcase #HealthcareInnovation

Share This Event

bottom of page